AKAM vs ELAB · P/E 27, rev $2.17B vs rev $2.0M
Akamai Technologies Inc (AKAM) versus Elevai Labs, Inc. Common Stock (ELAB) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. ELAB currently screens at market cap $6.5M.
Not investment advice. Open the AKAM and ELAB stock pages for the full models.
Not investment advice.